83 related articles for article (PubMed ID: 11505784)
1. Synthesis and hypolipidemic activity of modified side chain alpha-asarone homologues.
Cruz A; Garduño L; Salazar M; Martínez E; Jiménez-Vázquez HA; Díaz F; Chamorro G; Tamariz J
Arzneimittelforschung; 2001; 51(7):535-44. PubMed ID: 11505784
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and hypolipidemic and antiplatelet activities of alpha-asarone isomers in humans (in vitro), mice (in vivo), and rats (in vivo).
Poplawski J; Lozowicka B; Dubis AT; Lachowska B; Witkowski S; Siluk D; Petrusewicz J; Kaliszan R; Cybulski J; Strzałkowska M; Chilmonczyk Z
J Med Chem; 2000 Oct; 43(20):3671-6. PubMed ID: 11020281
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and hypolipidaemic evaluation of a series of alpha-asarone analogues related to clofibrate in mice.
Labarrios F; Garduño L; Vidal MR; Garcia R; Salazar M; Martinez E; Diaz F; Chamorro G; Tamariz J
J Pharm Pharmacol; 1999 Jan; 51(1):1-7. PubMed ID: 10197410
[TBL] [Abstract][Full Text] [Related]
4. alpha-asarone congeners as hypolipidemic agents. Pseudoreceptor versus minireceptor modeling.
Filipek S; Łozowicka B
Acta Pol Pharm; 2000 Nov; 57 Suppl():106-9. PubMed ID: 11293234
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and highly potent hypolipidemic activity of alpha-asarone- and fibrate-based 2-acyl and 2-alkyl phenols as HMG-CoA reductase inhibitors.
Mendieta A; Jiménez F; Garduño-Siciliano L; Mojica-Villegas A; Rosales-Acosta B; Villa-Tanaca L; Chamorro-Cevallos G; Medina-Franco JL; Meurice N; Gutiérrez RU; Montiel LE; Cruz Mdel C; Tamariz J
Bioorg Med Chem; 2014 Nov; 22(21):5871-82. PubMed ID: 25311563
[TBL] [Abstract][Full Text] [Related]
6. Effect of alpha-asarone and a derivative on lipids, bile flow and Na+/K+-ATPase in ethinyl estradiol-induced cholestasis in the rat.
Garduño-Siciliano L; Labarrios F; Tamariz J; Moreno MG; Chamorro G; Muriel P
Fundam Clin Pharmacol; 2007 Feb; 21(1):81-8. PubMed ID: 17227448
[TBL] [Abstract][Full Text] [Related]
7. Hypolipidaemic and antiplatelet activity of phenoxyacetic acid derivatives related to alpha-asarone.
Pérez-Pastén R; García RV; Garduño L; Reyes E; Labarrios F; Tamariz J; Chamorro G
J Pharm Pharmacol; 2006 Oct; 58(10):1343-9. PubMed ID: 17034657
[TBL] [Abstract][Full Text] [Related]
8. 3D QSAR study of hypolipidemic asarones by comparative molecular surface analysis.
Magdziarz T; Lozowicka B; Gieleciak R; Bak A; Polański J; Chilmonczyk Z
Bioorg Med Chem; 2006 Mar; 14(5):1630-43. PubMed ID: 16275105
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antifeedant activity of novel alpha-asarone derivatives against stored-product pests.
Łozowicka B; Kaczyński P
Pest Manag Sci; 2013 Aug; 69(8):964-74. PubMed ID: 23355356
[TBL] [Abstract][Full Text] [Related]
10. Genotoxicity of alpha-asarone analogues.
Karwicka E; Marczewska J; Anuszewska E; Łozowicka B; Chilmonczyk Z
Bioorg Med Chem; 2008 Jun; 16(11):6069-74. PubMed ID: 18487049
[TBL] [Abstract][Full Text] [Related]
11. Hypolipidemic activity of phthalimide derivatives IV: Further chemical modification and investigation of the hypolipidemic activity of N-substituted imides.
Chapman JM; Cocolas GH; Hall IH
J Pharm Sci; 1983 Nov; 72(11):1344-7. PubMed ID: 6644601
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of ethyl 2-(4-chlorophenyl)-5-(2-furyl)-4-oxazoleacetate, a hypolipidemic agent, and related compounds.
Moriya T; Seki M; Takabe S; Matsumoto K; Takashima K; Mori T; Odawara A; Takeyama S
J Med Chem; 1988 Jun; 31(6):1197-204. PubMed ID: 3373489
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and hypolipidemic activity of diesters of arylnaphthalene lignan and their heteroaromatic analogs.
Kuroda T; Kondo K; Iwasaki T; Ohtani A; Takashima K
Chem Pharm Bull (Tokyo); 1997 Apr; 45(4):678-84. PubMed ID: 9145504
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacology and toxicology of Guatteria gaumeri and alpha-asarone].
Chamorro G; Salazar M; Salazar S; Mendoza T
Rev Invest Clin; 1993; 45(6):597-604. PubMed ID: 8159883
[TBL] [Abstract][Full Text] [Related]
15. Heterocyclic analogues of chlorcyclizine with potent hypolipidemic activity.
Ashton MJ; Ashford A; Loveless AH; Riddell D; Salmon J; Stevenson GV
J Med Chem; 1984 Oct; 27(10):1245-53. PubMed ID: 6148419
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antihyperlipidemic activity of novel coumarin bisindole derivatives.
Sashidhara KV; Kumar A; Kumar M; Srivastava A; Puri A
Bioorg Med Chem Lett; 2010 Nov; 20(22):6504-7. PubMed ID: 20932744
[TBL] [Abstract][Full Text] [Related]
17. Treloxinate and related hypolipidemic 12H-dibenzo(d,g)(1,3)dioxocin-6-carboxylate derivatives.
Grisar JM; Parker RA; Kariya T; Blohm TR; Fleming RW; Petrow V; Wenstrup DL; Johnson RG
J Med Chem; 1972 Dec; 15(12):1273-8. PubMed ID: 4635973
[No Abstract] [Full Text] [Related]
18. Synthesis and quantitative structure-activity relationships of antihyperlipaemic 2-substituted thieno[3,2-d]pyrimidin-4(3H)-ones.
Shishoo CJ; Jain KS; Rathod IS; Thakkar BJ; Brahmbhatt SB; Gandhi TP; Bangaru R; Goyal RK
Arzneimittelforschung; 1996 Mar; 46(3):273-6. PubMed ID: 8901148
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the hypolipidemic activity of cyclic vs. acyclic imides.
Voorstad PJ; Chapman JM; Cocolas GH; Wyrick SD; Hall IH
J Med Chem; 1985 Jan; 28(1):9-12. PubMed ID: 3965717
[TBL] [Abstract][Full Text] [Related]
20. Molecular docking of the highly hypolipidemic agent alpha-asarone with the catalytic portion of HMG-CoA reductase.
Medina-Franco JL; López-Vallejo F; Rodríguez-Morales S; Castillo R; Chamorro G; Tamariz J
Bioorg Med Chem Lett; 2005 Feb; 15(4):989-94. PubMed ID: 15686898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
